Medakit

Medakit is a private healthcare diagnostics company focused on rapid, affordable, and easy-to-use diagnostic tests. Publicly available descriptions indicate the company develops point-of-care lateral flow immunoassays, initially for coronavirus testing, and has marketed rapid infectious disease tests including COVID-19 assays. The company appears to operate commercially rather than as a therapeutics developer, so it does not have a traditional drug pipeline. Available sources place the company in Hong Kong and identify Mike Touzard as founder. Medakit should be classified primarily as a medical device and diagnostics company rather than a biotech drug developer.